Skip to main content
IXICO PLC logo

IXICO PLC — Investor Relations & Filings

Ticker · IXI ISIN · GB00BFXR4C20 LEI · 2138005M1F59O6HWSA97 IL Professional, scientific and technical activities
Open in API
Filings indexed 354 across all filing types
Latest filing 2022-02-14 Regulatory Filings
Country GB United Kingdom
Listing IL IXI

About IXICO PLC

https://www.ixico.com/

IXICO PLC is a clinical research and data analytics company specializing in neuroscience. It provides neuroimaging and digital biomarker analytics to biopharmaceutical firms conducting clinical trials for neurological disorders. The company utilizes its proprietary, AI-driven technology platform to manage and analyze complex imaging and digital health data. This platform deploys disease-specific algorithms to generate reliable clinical data and precision insights, aiming to accelerate research and development decision-making, de-risk clinical studies, and support the advancement of new therapies for conditions such as Alzheimer's and Huntington's disease.

Recent filings

Filing Released Lang Actions
Launch of IXIQ.Ai Deep learning AI-based platform
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated February 14, 2022. It announces the 'Launch of IXIQ.Ai Deep learning AI-based platform' by IXICO plc. This is a specific operational and product announcement made via the Regulatory News Service (RNS) system of the London Stock Exchange. Since it is a general, timely announcement that does not fit into specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS), and it is clearly distributed through the RNS system, the most appropriate classification is Regulatory Filings (RNS), which serves as the general regulatory announcement fallback.
2022-02-14 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled as an 'RNS Number' and contains a 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership (crossing thresholds) to a regulatory body (implied by the RNS/LSE context). This directly matches the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the core content is a specific regulatory disclosure about share ownership change, making MRQ the most precise classification over the general RNS fallback.
2022-02-08 English
Contract award worth circa £1.0m
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated February 8, 2022. The content announces a significant contract award for clinical trial services related to neurodegenerative diseases. This type of announcement, detailing a specific business event, contract, or material development released via the Regulatory News Service (RNS) of the London Stock Exchange, fits best under the general 'Regulatory Filings' category, as it is not a formal financial report (10-K, IR, ER), a management change (MANG), or a shareholder vote result (DVA). It is a general regulatory announcement.
2022-02-08 English
Appointment of Senior Therapeutic Advisor
Regulatory Filings Classification · 1% confidence The document is an official announcement released via RNS (RNS Number : 0535A) on January 31, 2022. The content explicitly details the 'Appointment of Senior Therapeutic Advisor,' Dr. Lynne Hughes. This type of announcement, concerning changes in senior personnel or advisory roles, directly maps to the 'Board/Management Information' category. Although it is distributed via an RNS mechanism, the core subject matter is management/personnel change, making MANG the most specific classification over the general RNS fallback.
2022-01-31 English
Dementia collaboration
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated January 26, 2022. It announces a specific corporate event: IXICO plc extending its commitment to the Dementias Platform UK (DPUK) collaboration. The text is a formal announcement detailing business updates, quotes from management, and contact information, typical of a press release distributed via a regulatory news service. The presence of the RNS header and the nature of the content (a business update that isn't a full financial report, management change, or shareholder vote result) strongly suggests it is a general regulatory announcement. Since it is a specific business update distributed via RNS and doesn't fit perfectly into the other specific categories (like ER, 10-K, MANG, etc.), the most appropriate classification is the general regulatory filing category.
2022-01-26 English
Non-Executive Director Appointment
Board/Management Information Classification · 1% confidence The document is a formal announcement released via RNS (Regulatory News Service) with an RNS Number (1566Z) and a date (21 January 2022). The content explicitly announces the appointment of a Non-Executive Director and the retirement of another, detailing their roles and history. This directly corresponds to the definition of 'Board/Management Information' (MANG). Although it is distributed via RNS, the specific subject matter (Director Appointment) is more precise than the general 'RNS' fallback category.
2022-01-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.